Antipsychotics and dementia risk; biomarkers for lecanemab eligibility; trial of difelikefalin for neurogenic itch in notaliga paresthetica.
Neurology Today in 516 Mars 2023

Antipsychotics and dementia risk; biomarkers for lecanemab eligibility; trial of difelikefalin for neurogenic itch in notaliga paresthetica.

In this week's podcast, Neurology Today's editor-in-chief discusses the increased use of antipsychotics during the pandemic and an associated greater risk for dementia, determining the best biomarkers when considering lecanemab for Alzheimer's, and a novel approach for managing uncomfortable neuropathic symptoms.

Avsnitt(100)

November 18 - Issue Introduction

November 18 - Issue Introduction

Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the November 18, 2021 issue.

19 Nov 20215min

November 4- Issue Introduction

November 4- Issue Introduction

Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the November 4, 2021 issue.

8 Nov 20215min

October 21- Issue Introduction

October 21- Issue Introduction

Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the October 21, 2021 issue.

21 Okt 20215min

October 7- Issue Introduction

October 7- Issue Introduction

Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the October 7, 2021 issue.

7 Okt 20215min

Populärt inom Premium

mellan-himmel-och-jord-med-jlc
mardromsgasten
tutto-balutto
den-som-skrattar-forlorar-podcast-2
filip-fredrik-svarar
podme-dokumentar
rattsfallen
jocke-jonna-sanningen-maste-fram
infor-ratta
svenska-mordhistorier
hogt-i-tak-2
en-mork-historia
seriemordarpodden
blenda-2
daddy-issues
mordpodden
nemo-moter-en-van
sillypodden
sportbladets-premier-league-podd
bakom-galler